135809-98-2

Basic information

• Product Name: 4-[[2-(methoxycarbonyl)phenyl]methoxy]benzenepropanoic acid ethyl ester
• Synonyms: 4-[[2-(methoxycarbonyl)phenyl]methoxy]benzenepropanoic acid ethyl ester
• CAS NO: 135809-98-2
• Molecular Weight: 342.392
• Mol File: 135809-98-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-[[2-(methoxycarbonyl)phenyl]methoxy]benzenepropanoic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[[2-(methoxycarbonyl)phenyl]methoxy]benzenepropanoic acid ethyl ester(135809-98-2)
• EPA Substance Registry System: 4-[[2-(methoxycarbonyl)phenyl]methoxy]benzenepropanoic acid ethyl ester(135809-98-2)

Safety Data

• Hazardous Substances Data: 135809-98-2(Hazardous Substances Data)

Upstream product

• 2417-73-4 methyl 2-bromomethylbenzoate 
• 23795-02-0 3-(4-hydroxy-phenyl)-propionic acid ethyl ester 
• 501-97-3 4-hydroxyphenylpropionic acid 

Downstream Products

• 64088-81-9 3-[4-(2-Carboxybenzyloxy)-phenyl]-propionsaeure 

Relevant articles and documents

N-hydroxy-dibenz ?b,e!oxepinalkylamines, N-hydroxy-dibenz ?b,e!oxepinalkanoic acid amides and related heterocyclic analogues

This invention relates to N-hydroxy-dibenz?b,e!oxepinalkylamines, N-hydroxy-dibenz?b,e!oxepinalkanoic acid amides and related heterocyclic analogues of the formula STR1 where X together with the carbon atoms to which it is attached forms a benzene or thiophene ring; W and Z are independently hydrogen, halogen, loweralkyl, or trifluoromethyl; R1 is hydrogen, arylloweralkyl, loweralkoxycarbonyl, loweralkylcarbonyl, arylcarbonyl or arylloweralkylcarbonyl; R2 is loweralkyl, cycloalkyl, arylloweralkyl, loweralkoxycarbonyl, loweralkylcarbonyl, arylcarbonyl or arylloweralkylcarbonyl; m is 0 or 1 and n is an integer of 0 to 4 or the pharmaceutically acceptable salts thereof. The compounds of this invention are useful as analgesics and topical antiinflammatory agents for the treatment of various dermatoses and agents for the treatment of conditions where accumulation of cyclooxygenase and/or lipoxygenase metabolites is a causative factor.